Twitter's new owner Elon Musk's vision for a 'free speech' platform has some advertisers hitting pause.

Twit­ter ad­ver­tis­ing pause or per­sist? Phar­mas qui­et­ly weigh op­tions in un­cer­tain time

As Elon Musk’s takeover of Twit­ter — and al­most-dai­ly con­tro­ver­sies — caus­es con­fu­sion and con­ster­na­tion, brand ad­ver­tis­ers on the plat­form are try­ing to fig­ure out what to do. And that in­cludes phar­ma ad­ver­tis­ers.

So far, the lone pub­licly on-the-record phar­ma paus­ing its ad­ver­tis­ing on the plat­form is Gilead Sci­ences and its sub­sidiary Kite.

Gilead ini­tial­ly said last week that it was tem­porar­i­ly paus­ing Twit­ter ad­ver­tis­ing. How­ev­er, it amend­ed its stance on Mon­day to re­move the word “tem­porar­i­ly.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.